Literature DB >> 25017568

Cyclic AMP (cAMP) signaling in melanocytes and melanoma.

Carlos Iván Rodríguez1, Vijayasaradhi Setaluri2.   

Abstract

G-protein coupled receptors (GPCRs), which include melanocortin-1 receptor (MC1R), play a crucial role in melanocytes development, proliferation and differentiation. Activation of the MC1R by the α-melanocyte stimulating hormone (α-MSH) leads to the activation of the cAMP signaling pathway that is mainly associated with differentiation and pigment production. Some MC1R polymorphisms produce cAMP signaling impairment and pigmentary phenotypes such as the red head color and fair skin phenotype (RHC) that is usually associated with higher risk for melanoma development. Despite its importance in melanocyte biology, the role of cAMP signaling cutaneous melanoma is not well understood. Melanoma is primarily driven by mutations in the components of mitogen-activated protein kinases (MAPK) pathway. Increasing evidence, however, now suggests that cAMP signaling also plays an important role in melanoma even though genetic alterations in components of this pathway are note commonly found in melanoma. Here we review these new roles for cAMP in melanoma including its contribution to the notorious treatment resistance of melanoma.

Entities:  

Keywords:  Adenylate cyclases (ADCYs); Drug resistance; MAPK signaling; Melanocortin-1 receptor (MC1R); Phosphodiesterases (PDEs); cAMP Responsive Element Binding Protein (CREB)

Mesh:

Substances:

Year:  2014        PMID: 25017568     DOI: 10.1016/j.abb.2014.07.003

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  38 in total

1.  Elevated cyclic AMP levels promote BRAFCA/Pten-/- mouse melanoma growth but pCREB is negatively correlated with human melanoma progression.

Authors:  Carlos I Rodríguez; Edgardo Castro-Pérez; B Jack Longley; Vijayasaradhi Setaluri
Journal:  Cancer Lett       Date:  2017-11-24       Impact factor: 8.679

2.  PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.

Authors:  J Delyon; A Servy; F Laugier; J André; N Ortonne; M Battistella; S Mourah; A Bensussan; C Lebbé; N Dumaz
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

3.  Melanocortin-1 Receptor Polymorphisms and the Risk of Complicated Sepsis After Trauma: A Candidate Gene Association Study.

Authors:  Max E Seaton; Brodie A Parent; Ravi F Sood; Mark M Wurfel; Lara A Muffley; Grant E O'Keefe; Nicole S Gibran
Journal:  Shock       Date:  2017-01       Impact factor: 3.454

4.  A novel CDKN2A variant (p16L117P ) in a patient with familial and multiple primary melanomas.

Authors:  Christopher Li; Tong Liu; Bin Liu; Rolando Hernandez; Julio C Facelli; Douglas Grossman
Journal:  Pigment Cell Melanoma Res       Date:  2019-05-03       Impact factor: 4.693

5.  Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanoma.

Authors:  Rached Alkallas; Mathieu Lajoie; Dan Moldoveanu; Karen Vo Hoang; Philippe Lefrançois; Marine Lingrand; Mozhdeh Ahanfeshar-Adams; Kevin Watters; Alan Spatz; Jonathan H Zippin; Hamed S Najafabadi; Ian R Watson
Journal:  Nat Cancer       Date:  2020-06-22

Review 6.  The Function of Autophagy as a Regulator of Melanin Homeostasis.

Authors:  Ki Won Lee; Minju Kim; Si Hyeon Lee; Kwang Dong Kim
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

7.  EPAC-RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMP.

Authors:  Carlos I Rodríguez; Edgardo Castro-Pérez; Kirthana Prabhakar; Laura Block; B Jack Longley; Jaclyn A Wisinski; Michelle E Kimple; Vijayasaradhi Setaluri
Journal:  Mol Cancer Res       Date:  2017-08-29       Impact factor: 5.852

Review 8.  The pleiotropic role of exchange protein directly activated by cAMP 1 (EPAC1) in cancer: implications for therapeutic intervention.

Authors:  Muayad Almahariq; Fang C Mei; Xiaodong Cheng
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-11-02       Impact factor: 3.848

9.  Race and Melanocortin 1 Receptor Polymorphism R163Q Are Associated with Post-Burn Hypertrophic Scarring: A Prospective Cohort Study.

Authors:  Ravi F Sood; Anne M Hocking; Lara A Muffley; Maricar Ga; Shari Honari; Alexander P Reiner; Ali Rowhani-Rahbar; Nicole S Gibran
Journal:  J Invest Dermatol       Date:  2015-06-01       Impact factor: 8.551

10.  Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in human.

Authors:  Denis Shepelin; Mikhail Korzinkin; Anna Vanyushina; Alexander Aliper; Nicolas Borisov; Raif Vasilov; Nikolay Zhukov; Dmitry Sokov; Vladimir Prassolov; Nurshat Gaifullin; Alex Zhavoronkov; Bhupinder Bhullar; Anton Buzdin
Journal:  Oncotarget       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.